A candidate identification questionnaire for patients with postmenopausal osteoporosis switched from treatment with a daily or weekly bisphosphonate to once-monthly ibandronate
Makaleler > Tam Makale · 2011
Yazarlar: Y. Gokce Kutsal, N. Eskiyurt, J. Irdesel, V. Sepici, H. Ugurlu, Yeşim KİRAZLI, F. Ardic, M. Korsic, T. Vlak, M. Grlickov, S.M. Temelkova, M. Lazarov, N. Pilipovic, V. Popovic, A. Dimic, B. Kovacev, D. Ruci, A. Tafaj, E. Kucukalic-Selimovic, D. Avdic, H. Seleskovic, S. Pejicic, B. Butun, G. Akyuz, L. Cerrahoglu, O.F. Sendur, P. Yalcin, S. Oncel, M. Saridogan, T. Sarpel, M. Tosun, K. Senel, S. Gursoy, F. Cantürk, H. Demir, B. Miskic, D. Krpan, F. Skreb, S. Grazio, Z. Crncevic-Orlic, F. Ozdener, H. Oncel
Bone, Uluslararası, Wos, 2011, cilt 48, ss S233-S234